David Kelleher is CEO and co-founder of 4G Clinical, a venture-backed Randomization and Trial Supply Management (RTSM) company serving the global pharmaceutical market. Kelleher co-founded 4G to accelerate the commercialization of vital medications. Previously, David was principal and co-founder of ACME Business Consulting, a management, operations, project and strategy consulting firm headquartered in Portland, Oregon with offices in Seattle and San Diego. Kelleher formed ACME with his partners in 2002 to help organizations complete critical projects that advance, improve and streamline their ability to do business. Prior to ACME being acquired by North Highland in 2015, the firm was named to the Portland Business Journal’s list of “Fastest-Growing Private 100 Companies” for 8 of the previous 9 years.
Kelleher earned his Bachelor of Science degree in Biology from Duke University and is also a graduate of the United States Army Infantry Officer Basic School, Airborne School and Ranger School. Diagnosed with multiple sclerosis in 1996 while serving in the 82nd Airborne Division in Vicenza, Italy, Kelleher is active in finding a cure for the disease. He served on the board of the Oregon Chapter of the National MS Society from 2005–2013 including a two-year stint as the board chair as well as multiple national roles. Kelleher has also served on the board of directors for Janus Youth Programs, Greater Portland, Inc., Junior Achievement and Home Forward (formerly Housing Authority of Portland). He resides in Northeast Portland with his wife, Kysa, and their six children.